Skip Navigation

Meet the Class of 2016 Fellows

Mary Lancaster

Mary  Lancaster

Dr. Mary Lancaster is AFRICOM Science Lead for the Cooperative Biological Engagement Program (CBEP) of the Cooperative Threat Reduction Program (CTR). Dr. Lancaster manages CBEP’s cooperative biological research and biosurveillance efforts with CBEP partner countries in Central and West Africa, including Cameroon, Cote d’Ivoire, Ethiopia, Gabon, Guinea, Liberia, Senegal, Sierra Leone, and Uganda. Cooperative biological research projects are focused on supporting and bolstering BS&S and biosurveillance capabilities that reduce the threat of pathogens of security concern, while addressing infectious disease priorities of both CBEP and its partner countries.  Dr. Lancaster influences the strategy for the AFRICOM Science portfolio, coordinates the submission of research project proposals with potential collaborators and manages ensuing projects.

From 2010 to 2015, Dr. Lancaster was a research scientist at Pacific Northwest National Laboratory, where she applied her expertise in epidemiology and data analysis to a broad range of projects, including vector surveillance lead in the Republic of Georgia, cyber-physical risk and vulnerability assessments, development of cybersecurity resilience metrics, evaluation of stand-off rad/nuc detection implementation for DHS’ Domestic Nuclear Detection Office, and development of a proof-of-concept decision support tool for biological event response that integrated epidemiologic modeling with decision theory to guide decision making under uncertainty. Since 2014, Dr. Lancaster has chaired the Institutional Review Board at PNNL. In December 2014, Dr. Lancaster was detailed to DHHS/BARDA as a liaison between BARDA’s Analytic Decision Support Division and the modeling and simulation expertise found in DOE National Laboratories.

From 2006-2010, Dr. Lancaster was the regional epidemiologist in the West Tennessee Region of the Tennessee Department of Health. Dr. Lancaster developed and implemented a regional syndromic surveillance program, performed routine disease surveillance, investigated disease outbreaks, and collaborated in the development of preparedness and response plans for natural and man-made disasters.  In addition, she drafted a quarterly communicable disease newsletter for healthcare providers in the region and served as deputy public information officer during the 2009 H1N1 influenza outbreak.

In graduate school, Dr. Lancaster investigated the introduction and establishment of the Asian tiger mosquito (Aedes albopictus) in a LaCrosse virus encephalitis endemic area and aided in the development of risk maps for Lyme disease in the upper Midwest.

Previously, Dr. Lancaster held an emergency medical technician (EMT) license for 16 years, working for both a private ambulance company and a student-run volunteer EMS organization at the University of Illinois.

View Profile

Stephanie Griese

Stephanie  Griese

Dr. Stephanie Griese is a medical epidemiologist in the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention in Atlanta, Georgia. Her focus areas include pediatric preparedness, vulnerable populations, and medical countermeasures.  Dr. Griese recently served as the Lead for the Ebola Children’s Health Team, where she directed a multidisciplinary team of clinicians, epidemiologists, health scientists, public health advisors, and health communicators to ensure the unique needs of children were recognized and addressed in all aspects of CDC’s Ebola Outbreak response.  Dr. Griese earned her undergraduate degrees (BS, BA) from the College of William and Mary, her medical degree from the Penn State College of Medicine, and a Masters of Public Health from the Johns Hopkins Bloomberg School of Public Health.  She completed her pediatrics residency training at the Johns Hopkins Hospital, and practiced in the Johns Hopkins Hospital Pediatric Emergency Department prior to a career in public health.  She served as a CDC Epidemic Intelligence Service Officer for two years with the North Carolina Division of Public Health before joining CDC’s Office of Public Health Preparedness and Response as a medical epidemiologist in 2013.  

View Profile










Behind the Scenes in Biosecurity

Phyllis Arthur Interview

Phyllis Arthur, Senior Director, Vaccines, Immunotherapeutics and Diagnostics Policy, Biotechnology Industry Organization (BIO), discusses the role of public-private partnerships in drug and vaccine development and production and broadly outlines the roles that Congress, the Administration, and the private sector play regarding US biodefense policy.